Yahoo

Novo Nordisk Could Win the Oral GLP-1 Race Against Lilly. Why It Just Raised Guidance.

Novo Nordisk Could Win the Oral GLP-1 Race Against Lilly. Why It Just Raised Guidance. · Barrons.com
Explore stocks on Coinbase

Novo Nordisk stock rose as it raised its guidance on the back of the strong performance of its weight-loss pill.

Mobilize your Website
View Site in Mobile | Classic
Share by: